Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Moderna exits Metagenomi gene editing deal worth $3B biobucks
Earlier this year, Metagenomi had the spotlight with a $93.7 million IPO. Now, Moderna is exiting a partnership worth up to $3 billion in biobucks.
Gabrielle Masson
May 1, 2024 4:00pm
Pfizer plans to be 'very active' in obesity despite setbacks
May 1, 2024 1:42pm
Astellas hops into Poseida's car for $50M cell therapy collab
May 1, 2024 12:49pm
Hologic picks up breast cancer marker maker Endomag for $310M
May 1, 2024 12:00pm
Bob Nelsen on megarounds, Altos and psychedelics
May 1, 2024 10:56am
Pepper spices up pipeline with $135M deal for G1's cancer drug
May 1, 2024 10:32am
Medtech News
Quest Diagnostics carves out PathAI's digital pathology lab
May 1, 2024 10:30am
GE HealthCare's Q1 falls flat after China sales slide
Apr 30, 2024 11:43am
Philips signs $1.1B settlement for CPAP personal injury claims
Apr 29, 2024 4:12pm
Labcorp nets companion Dx OK for Pfizer hemophilia gene therapy
Apr 29, 2024 1:56pm
See More Medtech News